Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled study

Publication date: Available online 31 May 2020Source: Journal of Psychiatric ResearchAuthor(s): Makoto Kamiya, Helene D. Sabia, Julie Marella, Maurizio Fava, Charles B. Nemeroff, Hideo Umeuchi, Michihiko Iijima, Shigeyuki Chaki, Izumi Nishino

Source: Journal of Psychiatric Research - June 1, 2020 Category: Psychiatry Source Type: research